Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -56.04% is 365% below its 4-year average of -12.05%, near the low end of its 4-year range (-56.04%–14.46%).
As of the fiscal period ended Wednesday, December 31, 2025. 70.15% below its 12-month average of -32.94%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -22.03%.
RETURN ON ASSETS (ROA)
-56.04%
RETURN ON ASSETS (ROA) AVG TTM
-32.94%
RETURN ON ASSETS (ROA) AVG 3Y
-18.68%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-70.15%
CURRENT VS 3Y AVG
-199.96%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-73.82%
vs the sector median at left
iTonic Holdings Ltd.
Market Cap
$25.98M
Return on Assets (ROA)
-56.04%
TTM Avg
-32.94%
3Y Avg
-18.68%
5Y Avg
N/A
Market Cap
$25.76M
Return on Assets (ROA)
-86.25%
TTM Avg
-69.34%
3Y Avg
-63.87%
5Y Avg
-58.73%
Market Cap
$27.15M
Return on Assets (ROA)
-457.14%
TTM Avg
-445.84%
3Y Avg
-483.30%
5Y Avg
-427.37%
Market Cap
$24.54M
Return on Assets (ROA)
-116.81%
TTM Avg
-53.20%
3Y Avg
-39.87%
5Y Avg
-35.95%
Market Cap
$24.18M
Return on Assets (ROA)
-40.73%
TTM Avg
-51.29%
3Y Avg
-88.21%
5Y Avg
-85.48%
Market Cap
$27.79M
Return on Assets (ROA)
-22.11%
TTM Avg
-50.36%
3Y Avg
-51.04%
5Y Avg
-41.44%
Market Cap
$23.96M
Return on Assets (ROA)
181.24%
TTM Avg
65.61%
3Y Avg
3.99%
5Y Avg
-7.40%
Market Cap
$28.14M
Return on Assets (ROA)
-87.08%
TTM Avg
-72.41%
3Y Avg
-58.48%
5Y Avg
-50.84%
Market Cap
$23.15M
Return on Assets (ROA)
-0.58%
TTM Avg
-3.56%
3Y Avg
23.24%
5Y Avg
-18.31%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iTonic Holdings Ltd. (ITOC) | $25.98M | -56.04% | -32.94% | -18.68% | N/A |
| InspireMD, Inc. (NSPR)vs › | $25.76M | -86.25% | -69.34% | -63.87% | -58.73% |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $27.15M | -457.14% | -445.84% | -483.30% | -427.37% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.54M | -116.81% | -53.20% | -39.87% | -35.95% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.18M | -40.73% | -51.29% | -88.21% | -85.48% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.79M | -22.11% | -50.36% | -51.04% | -41.44% |
| Kyntra Bio, Inc. (KYNB)vs › | $23.96M | 181.24% | 65.61% | 3.99% | -7.40% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.14M | -87.08% | -72.41% | -58.48% | -50.84% |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.15M | -0.58% | -3.56% | 23.24% | -18.31% |
| OneMedNet Corporation (ONMD)vs › | $29.05M | -623.61% | -201.00% | -2514.84% | -1875.48% |
ROA
-56.0%
ROE
-83.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -56.04% |
| 2024-12-31 | -9.83% |
| 2023-12-31 | -14.85% |
| 2022-12-31 | 5.99% |
| 2021-12-31 | 14.46% |
